期刊文献+

华氏巨球蛋白血症1例 被引量:2

Waldenstrm Macroglobulinemia:a case report and literature review
原文传递
导出
摘要 患者,男,60岁。因"双眼睑水肿、头痛4个月余,加重7d"于4月7日入住我科。起病后在当地医院诊断不明,治疗无效。既往有鼻窦炎病史。入院体检:神清,查体欠合作。贫血貌,鼻腔出血,双下肢及眼睑水肿,浅表淋巴结不大,心肺听诊无异常,腹软,肝肋下未及,脾平脐。脐偏右扪及一鸭蛋大小包块,与各脏器关系不清。 To explore the clinical features and laboratory diagnosis of this disease. The clinical data of Waldenstrom Macroglobulinemia (WM) was reported and the literatures were reviewed. The old male patient suffered from headache and double eyelid edema. Coomhs test result was(A-A-A-+). Free hemoglobin level was 65.79 rag/ L. Lymphoplasmaeytic infiltration was found in bone marrow and peripheral blood. Monoclonal IgM protein level was 70.3 g/L. WM is characterized with lymphoplasmacytic in bone marrow and monoclonal IgM protein detection. WM is easily confused with IgM MM and small type B cell lymphoma. It is important to improve the recogni- tion of this disease.
出处 《临床血液学杂志》 CAS 2013年第3期339-341,共3页 Journal of Clinical Hematology
关键词 华氏巨球蛋白血症 浆细胞样淋巴细胞 CD5 CD10 Waldenstrom Macroglobulinemia Lymphoplasmacytic
  • 相关文献

参考文献15

  • 1The Non-Hodgkins Lymphoma Classification project.A clinical evaluation of the International LymphomaStudy Group Classification of Non-Hodgkin/s Lym-phoma[J]. Blood, 1997,89 :3909-3918.
  • 2SWERDLOW S H,BERGER F,PILERI S A, et al.Lymphoplasmacytic lymphoma [ M ]//SWERDLOWSHXAMPO E,HARIS N L,et al. World Health Or-ganization Classification of Tumours Tumors ofHaematopoietic and Lymphoid Tissues. Lyon: IARCPress, 2008 : 194_ 195.
  • 3GROVES F D, TRAVIS L B,DEVESA S S, et al.Waldenstrom's macroglobulinemia ; incidence patternsin the United States, 1988 — 1994 [J]. Cancer,1998,82:1078—1081.
  • 4FONSECA R, HAYMAN S. Waldenstrom macroglob-ulinemia[J]. Br J Haematol,2007,138:700 — 720.
  • 5BERGER F,ISAACSON P G,PIRIS M A,et al. Lym-phoplasmacytic lymphoma/Waldenstrom macroglobu-linemia[J]. In:JAFFE E S, HARRIS N L,STEIN H,et al,eds. World Health Organization Classification ofTumours : Pathology and Genetics of Tumours ofHaematopoietic and Lymphoid Tissues. Lyon,France:IARC Press,2001:132 —134.
  • 6TREON S P,GERTZ M A,DIMOPOULOS M,et al.Update on treatmengt recommendations from theThird International Workshop on Waldenstrom's mac-roglobulinemia[J]. Blood, 2006 ,107 : 3442 — 3446.
  • 7MELE A,PULSONI A,BIANCO E,et al. Hepatitis Cvirus and B cell non-Hodgkin lymphoms : an Italianmulticenter case-control study [J ]. Blood, 2003,102 :996-999.
  • 8TREON S P, HUNTER Z R,AGGARWAL A,et al.Characterization of familial Waldenstrom's macroglob-ulinemia[J], Ann Oncol,2006,17 :488 — 494.
  • 9ANSELL S M ,KYLE R A,REEDER M B,et al. Di-agnosis and management of Waldenstrom macroglobu-lincmia: Mayo stratification of macroglobulinemia andrisk-adapted therapy ( mSMART ) guildelines [ J ].Mayo Clin Proc,20l0 ,85 : 824_833.
  • 10TREON S P. How I treat Waldenstrom macroglobu-lincmia[J]. Blood ,2009 ,114:2375 — 2385.

同被引文献34

  • 1蒋道怡,王红,郭建军.主要表现为贫血的原发性巨球蛋白血症[J].临床误诊误治,2005,18(9):636-636. 被引量:2
  • 2Owen R G, Treon S P, A1 Katib A, et al. Clinicopatho- logical definition of Waldenstrom "s macroglobulinemia: consensus panel recommendations from the Second Inter- national Workshop on Waldenstrom "s Macroglobulinemia [J]. Semin Oncol, 2003,30(2) :110-115.
  • 3Treon S P, Hunter Z R, Aggarwal A, et al. Characteriza- tion of familial Waldenstroms macroglobulinemia[ J]. Ann Oncol, 2006,17 ( 3 ) :488-494.
  • 4Ansell S M, Kyle R A, Reeder C B, et al. Diagnosis and management of Waldenstrom macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted thera- py (mSMART) guidelines[ J]. Mayo Clin Proc, 2010,85 (9) :824-833.
  • 5Gertz M A, Merhni G, Treon S P. Amyloidosis and Wal- denstrom "s macroglobulinemia [ J ]. Hematology ( Am Soc Hematol Educ Program) , 2004:257-282.
  • 6Gertz M A. Waldenstrom macroglobulinemia [ J]. Hema- tology, 2012,17 ( Suppl 1 ) : 112-116.
  • 7Sekhar J, Sanfilippo K, Zhang Q, et al. Waldenstrom macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005 [ J]. Leuk Lymphoma, 2012,53 ( 8 ) : 1625-1626.
  • 8Gertz M A. Waldenstrom macroglobulinemia: 2013 up- date on diagnosis, risk stratification, and management [J]. Am J Hematol, 2013,88(8) :703-711.
  • 9Graziani M, Merlini G, Petrini C. Guidelines for the a- nalysis of Bence Jones protein [ J ]. Clin Chem Lab Med, 2003,41 ( 3 ) :338-346.
  • 10International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple mye- loma and related disorders: a report of the International Myeloma Working Group [ J]. Br J Haematol, 2003,121 (5) :749-757.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部